ADVERTISEMENT
Axis Securities: Dr. Reddy’s Strong Growth Across Business Verticals
Dr. Reddy’s revenue across verticals grew 20% year-on-year in Q2 on the back of new product launches and geographical expansion.
29 Oct 2020, 10:09 PM IST 
A worker walks past the Leadership Academy building, on the Dr. Reddy’s Laboratories Ltd. campus in Hyderabad, India (Photographer Prashanth Vishwanathan/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
I’m already a Subscriber Sign In
To continue reading this storySubscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
